News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
457,854 Results
Type
Article (24280)
Company Profile (146)
Press Release (433428)
Multimedia
Podcasts (30)
Webinars (7)
Section
Business (124733)
Career Advice (443)
Deals (20442)
Drug Delivery (42)
Drug Development (79185)
Employer Resources (44)
FDA (12590)
Job Trends (9522)
News (234413)
Policy (18854)
Tag
Academia (1723)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (81)
Alliances (33865)
ALS (93)
Alzheimer's disease (1352)
Antibody-drug conjugate (ADC) (122)
Approvals (12597)
Artificial intelligence (241)
Autoimmune disease (20)
Automation (10)
Bankruptcy (146)
Best Places to Work (8392)
BIOSECURE Act (12)
Biosimilars (65)
Biotechnology (114)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (270)
Cancer (2168)
Cardiovascular disease (164)
Career advice (388)
Career pathing (14)
CAR-T (151)
Cell therapy (397)
Cervical cancer (20)
Clinical research (65795)
Collaboration (695)
Compensation (400)
Complete response letters (22)
COVID-19 (2051)
CRISPR (32)
C-suite (202)
Cystic fibrosis (91)
Data (2160)
Decentralized trials (2)
Denatured (16)
Depression (46)
Diabetes (227)
Diagnostics (5143)
Digital health (13)
Diversity (8)
Diversity, equity & inclusion (17)
Drug discovery (101)
Drug pricing (24)
Drug shortages (10)
Duchenne muscular dystrophy (83)
Earnings (47807)
Editorial (19)
Employer branding (3)
Employer resources (42)
Events (73698)
Executive appointments (592)
FDA (13725)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (636)
Gene editing (90)
Generative AI (23)
Gene therapy (272)
GLP-1 (523)
Government (2273)
Grass and pollen (4)
Guidances (49)
Healthcare (13929)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (104)
Indications (30)
Infectious disease (2164)
Inflammatory bowel disease (139)
Inflation Reduction Act (2)
Influenza (44)
Intellectual property (80)
Interviews (60)
IPO (10927)
IRA (8)
Job creations (1492)
Job search strategy (349)
Kidney cancer (11)
Labor market (18)
Layoffs (289)
Leadership (7)
Legal (2438)
Liver cancer (65)
Lung cancer (316)
Lymphoma (145)
Machine learning (5)
Management (14)
Manufacturing (191)
MASH (62)
Medical device (9313)
Medtech (9313)
Mergers & acquisitions (9995)
Metabolic disorders (541)
Multiple sclerosis (75)
NASH (14)
Neurodegenerative disease (93)
Neuropsychiatric disorders (21)
Neuroscience (1865)
NextGen: Class of 2025 (4077)
Non-profit (2507)
Now hiring (19)
Obesity (259)
Opinion (138)
Ovarian cancer (71)
Pain (81)
Pancreatic cancer (79)
Parkinson's disease (146)
Partnered (13)
Patents (170)
Patient recruitment (113)
Peanut (43)
People (37788)
Pharmaceutical (34)
Pharmacy benefit managers (1)
Phase I (21194)
Phase II (29334)
Phase III (21228)
Pipeline (1090)
Policy (39)
Postmarket research (2054)
Preclinical (7629)
Press Release (28)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (342)
Real estate (2941)
Recruiting (16)
Regulatory (15889)
Reports (24)
Research institute (1850)
Resumes & cover letters (60)
Rett syndrome (5)
RNA editing (4)
RSV (26)
Schizophrenia (64)
Series A (119)
Series B (82)
Service/supplier (8)
Sickle cell disease (42)
Special edition (12)
Spinal muscular atrophy (143)
Sponsored (17)
Startups (2400)
State (1)
Stomach cancer (12)
Supply chain (36)
Tariffs (6)
The Weekly (14)
Vaccines (486)
Venture capitalists (24)
Weight loss (136)
Women's health (30)
Worklife (6)
Date
Today (4)
Last 7 days (723)
Last 30 days (2077)
Last 365 days (27310)
2025 (8966)
2024 (29331)
2023 (33254)
2022 (41170)
2021 (43121)
2020 (39909)
2019 (31439)
2018 (23576)
2017 (23928)
2016 (21769)
2015 (25439)
2014 (18407)
2013 (13839)
2012 (14506)
2011 (14928)
2010 (13994)
Location
Africa (360)
Alabama (44)
Alaska (3)
Arizona (121)
Arkansas (8)
Asia (28473)
Australia (5426)
California (5323)
Canada (1522)
China (472)
Colorado (226)
Connecticut (234)
Delaware (122)
Europe (63374)
Florida (714)
Georgia (171)
Idaho (39)
Illinois (331)
India (16)
Indiana (232)
Iowa (6)
Japan (139)
Kansas (78)
Kentucky (21)
Louisiana (6)
Maine (25)
Maryland (653)
Massachusetts (3902)
Michigan (130)
Minnesota (242)
Mississippi (1)
Missouri (56)
Montana (27)
Nebraska (16)
Nevada (46)
New Hampshire (52)
New Jersey (1395)
New Mexico (26)
New York (1490)
North Carolina (810)
North Dakota (5)
Northern California (2370)
Ohio (151)
Oklahoma (13)
Oregon (29)
Pennsylvania (1141)
Puerto Rico (8)
Rhode Island (16)
South America (483)
South Carolina (16)
Southern California (2033)
Tennessee (71)
Texas (802)
United States (19026)
Utah (137)
Virginia (119)
Washington D.C. (41)
Washington State (467)
West Virginia (1)
Wisconsin (38)
457,854 Results for "prc clinical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer Research (AACR) Annual Meeting
April 28, 2025
·
6 min read
Pharm Country
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
Milestone Scientific Inc. today announced that it has commenced sales of CompuFlo ® Epidural disposables into PRC Alliance Pain Relief Center at Ormond Beach, Florida.
April 3, 2024
·
4 min read
Policy
BioRestorative Therapies Enters into Letter of Intent with PRC Clinical
BioRestorative Therapies, Inc., a life sciences company focused on adult stem cell-based therapies, announced that it has entered into a letter of intent with PRC Clinical, a CRO specializing in clinical trial management, with regard to PRC Clinical providing startup clinical project management activities for the Company’s BRTX-100 Phase 2 clinical trial to treat chronic lumbar disc disease.
November 19, 2021
·
4 min read
Press Releases
Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs
April 21, 2025
·
9 min read
Press Releases
Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications
April 1, 2025
·
4 min read
Press Releases
Cellares and University of Wisconsin School of Medicine and Public Health to Automate Clinical-Scale Production of CRISPR-Edited CAR-T for Solid Tumors
April 10, 2025
·
5 min read
BioMidwest
Vizient Expands Contract with PRC to Include CARES™ Connect Discharge Solution
PRC, a leader in the healthcare intelligence space, announced today that it will be including CARES™ Connect—an innovative discharge solution designed to improve patient perceptions, increase HCAHPS scores, and reduce hospital readmissions—as part of their exclusive Vizient member offerings.
July 6, 2022
·
3 min read
Press Releases
Gyre Therapeutics Announces Publication of Protocol for Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis in Journal of Clinical and Translational Hepatology
March 28, 2025
·
5 min read
Press Releases
Mosaic Therapeutics In-Licenses Two Clinical-Stage Oncology Programs From Astex Pharmaceuticals for Development as Proprietary Combination Therapies
April 24, 2025
·
3 min read
Press Releases
Newleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate Growth
April 8, 2025
·
3 min read
1 of 45,786
Next
